Another study has found that prostaglandin (PGE2) participates in the progression of CCA via EP3 receptors, which trigger PI3K/AKT/GSK-3β pathway to up-regulate the expression of β-catenin proteins [68]. This evidence concerns the gene GSK3B and cholangiocarcinoma.